UnitedHealth Group Incorporated $UNH Shares Sold by Bingham Private Wealth LLC

Bingham Private Wealth LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 23.4% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,317 shares of the healthcare conglomerate’s stock after selling 403 shares during the quarter. Bingham Private Wealth LLC’s holdings in UnitedHealth Group were worth $411,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of UNH. Hardy Reed LLC increased its stake in shares of UnitedHealth Group by 41.7% during the second quarter. Hardy Reed LLC now owns 5,933 shares of the healthcare conglomerate’s stock worth $1,851,000 after purchasing an additional 1,745 shares in the last quarter. Spear Holdings RSC Ltd purchased a new stake in UnitedHealth Group during the 2nd quarter worth approximately $62,688,000. Country Club Bank lifted its position in shares of UnitedHealth Group by 120.6% in the second quarter. Country Club Bank now owns 18,567 shares of the healthcare conglomerate’s stock valued at $5,739,000 after acquiring an additional 10,151 shares in the last quarter. Seamount Financial Group Inc. increased its position in shares of UnitedHealth Group by 4.7% during the second quarter. Seamount Financial Group Inc. now owns 818 shares of the healthcare conglomerate’s stock worth $255,000 after purchasing an additional 37 shares in the last quarter. Finally, SteelPeak Wealth LLC raised its stake in UnitedHealth Group by 68.7% in the 2nd quarter. SteelPeak Wealth LLC now owns 10,070 shares of the healthcare conglomerate’s stock valued at $3,141,000 after purchasing an additional 4,101 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $358.95 on Tuesday. The company has a market capitalization of $325.09 billion, a P/E ratio of 15.55, a P/E/G ratio of 2.34 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The stock’s fifty day moving average is $309.38 and its two-hundred day moving average is $352.34.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the business posted $6.80 earnings per share. The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent research reports. JPMorgan Chase & Co. reduced their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Royal Bank Of Canada cut their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Cantor Fitzgerald reiterated an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Finally, Morgan Stanley upped their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Hold” and an average price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.